Double chamber tissue expander

• US 5,630,843 A
• Filed: 06/30/1994
• Issued: 05/20/1997
• Est. Priority Date: 06/30/1994
• Status: Expired due to Fees

• Current Assignee: Paul H. Rosenberg
• Original Assignee: Paul H. Rosenberg
• Inventors: Rosenberg, Paul H.
• Primary Examiner(s): Weiss, John G.
• Assistant Examiner(s): SNOW, BRUCE EDWARD
• Application Number:
  US08/268,508
• Time in Patent Office: 1,055 Days
• Field of Search: 623/8, 604/890.1, 604/891.1, 604/101, 606/191, 606/192, 600/31
• US Class Current: 623/8
• CPC Class Codes: A61B 90/02 Devices for expanding tissue, e.g. skin tissue implements for holding wounds open, surgical tractors A61B17/02; implantable mammary prosthesis A61F2/12; dilators A61M29/00
• CPC Class Codes: A61F 2/12 Mammary prostheses and implants

Abstract

A tissue expansion device for subcutaneous implantation in a patient consisting of an implantable expandable bladder prepared from a porous material which defines an infusion solution chamber, and an inner bladder disposed within the outer bladder prepared from an expandable non-porous material which defines an expansion solution chamber. Liquid transport means are provided for introducing and removing an infusion solution into and out of the infusion solution chamber, and fluid transport means are provided for introducing and removing an expansion fluid into and out of the expansion solution chamber. Following implantation of the tissue expansion device subcutaneously, expansion fluid can be introduced into the expansion chamber by use of the fluid transport means causing the inner bladder to expand. The expansion of the inner bladder exerts pressure on the infusion chamber, which contains infusion solution introduced through the liquid transport means. The infusion solution passes through the pores of the expandable porous material into the tissue surrounding and contacting the expansile porous wall of the implanted tissue expansion device. The outer bladder also expands, due primarily to expansion of the inner bladder and to introduction of infusion solution. The infusion solution can contain agents to facilitate the expansion process, such as hyaluronidase, lidocaine, epidermal growth factor, or dexamethasone, or any combination thereof.

Claims

1. A tissue expansion device for subcutaneous implantation and delivery of a tissue expansion promoter in a patient comprising:

an expansion and delivery means for subcutaneous implantation and tissue expansion comprising an expandable outer bladder prepared from a stretchable porous material capable of discharging an infusion solution therethrough, and

an expandable inner bladder disposed within said outer bladder and prepared from a stretchable non-porous material, which inner bladder and outer bladder are non-adherent, said inner bladder serving to effectuate the majority of the expansion of said expansion and delivery means;

wherein said inner and outer bladders are attached to a substantially non-stretchable and non-expandable rigid backplate member;

means for delivering said infusion solution adapted for location external to said patient in use, and in fluid communication with an interior of said outer bladder; and

means for inflating said inner bladder adapted for location external to said patient in use, and in fluid communication with an interior of said inner bladder.

2. The device of claim 1 further including means for preventing adhesion of the inner bladder to the outer bladder.

3. The device of claim 1 further including first liquid transport means associated with said infusion solution delivering means, for delivering said infusion solution to said outer bladder, and a second fluid transport means associated with said inflating means for introducing and removing an expansion fluid into and out of said inner bladder.

4. The tissue expansion device according to claim 1 in which the stretchable porous material is perforated silicone.

5. The tissue expansion device according to claim 1 wherein said outer bladder contains an infusion solution, and said infusion solution comprises an agent selected from the group consisting of an antibiotic, an anesthetic, an extracellular matrix digestive enzyme, a growth factor, and an agent that inhibits one or more of the conditions of fibrosis, capsule formation, or scar formation.

6. The tissue expansion device according to claim 1 in which said outer bladder contains an infusion solution selected from the group consisting of water, buffered saline, and saline.

7. The tissue expansion device according to claim 1 in which stretchable non-porous material is silicone.

8. The tissue expansion device according to claim 1 wherein said inner bladder contains an expansion fluid selected from the group consisting of buffered saline, saline, water, and air.

9. The tissue expansion device according to claim 1 in which said infusion solution delivery means is tubular wherein one end is in liquid communication with the interior of said outer bladder, and the opposite end extends to a first injection port.

10. The tissue expansion device according to claim 1 in which said inflating means is tubular wherein one end is in fluid communication with the interior of said inner bladder, and the opposite end extends to a second injection port.

11. The tissue expansion device according to claim 1 in which said infusion solution delivery means is tubular wherein one end is in liquid communication with the interior of said outer bladder and the opposite end extends to a first injection port;

and the inflation means is tubular wherein one end is in fluid communication with the interior of said inner bladder and the opposite end extends to second injection port.

12. The liquid transport means of claim 11 in which said inflation means is located co-axially inside said infusion solution delivery means.

13. The tissue expansion device of claim 1 which is round.

14. The tissue expansion devise of claim 13 which is round.